NCT07190118View on ClinicalTrials.gov

Effects of Emicizumab Treatment in Patients With Hemophilia A

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

November 10, 2025

Study Completion Date

February 10, 2026

Conditions
Hemophilia AMusculoskeletal AssessmentMusculoskeletal Abnormalities
Trial Locations (1)

(505) 090-5846

Hasan Kalyoncu University, Gaziantep

All Listed Sponsors
lead

Hasan Kalyoncu University

OTHER

NCT07190118 - Effects of Emicizumab Treatment in Patients With Hemophilia A | Biotech Hunter | Biotech Hunter